Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Heliox om arbejdet med vejrtrækning hos voksne patienter med stenose i nedre luftveje

18. september 2026 opdateret af: Marta Corral Blanco, Hospital Universitario 12 de Octubre

Effekten af ​​Heliox på arbejdet med vejrtrækning hos voksne patienter med stenose i nedre luftveje

Heliox (a mixture of Helium and Oxygen) can reduce the work of breathing in patients with airway stenosis by modifying turbulent flow into laminar flow. The aim of this study was to analyze the effect of Heliox versus conventional oxygen therapy in patients with lower airway stenosis on muscular effort measured by electromyography and diaphragmatic ultrasound, thoracoabdominal synchrony assessed with plethysmographic bands, dyspnea, stridor, oxygen saturation, transcutaneous carbon dioxide value, blood pressure, heart rate and respiratory rate.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Lower airway stenosis results in increased work of breathing with stridor and dyspnea, as a consequence of the increased resistances caused by the reduction in airway diameter. Airway resistance also depends on the length of the airway and the type of gas flow. Heliox (a mixture of Helium and Oxygen) is a gas less dense than air, which can change the flow from turbulent to laminar, reducing airway resistance by 20 to 40%, and therefore decreasing the work of breathing. Heliox is an inert gas that does not react with biological membranes, so there are few complications associated with its use, the most relevant being hypoxemia when fixed mixtures are not used and the the fraction of inspired oxygen (FiO2) supplied is less than 21%. The aim of the study was to evaluate if during the perioperative period of lower airway stenosis the administration of Heliox compared to oxygen could reduce the work of breathing and improve dyspnea. For this purpose, patients were treated for 30 minutes with Heliox (fixed mixture of 70% helium and 30% oxygen) using a non rebreather mask or reservoir bag versus 30 minutes with oxygen 31% using a Venturi mask.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

18

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Madrid
      • Madrid, Madrid, Spanien, 28041
        • Marta Corral Blanco

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 80 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Patients will be recluted from the pneumology outpatient clinic of the Hospital 12 de Octubre

Beskrivelse

Inclusion Criteria:

  • Patients with lower airway stenosis evaluated at the Respiratory Endoscopy Unit of the Hospital Universitario 12 de Octubre on the waiting list for endoscopic intervention on stenosis.
  • Stenosis grade ≥ 3 and Borg scale score > 2.

Exclusion Criteria:

  • Presence of relevant comorbidities (uncontrolled ischemic heart disease, ventricular dysfunction, pneumopathies with severe respiratory insufficiency, severe pulmonary hypertension).
  • Inability to perform the test due to severe dyspnea or need for emergency intervention.
  • Patient on continuous mechanical ventilation, invasive or non-invasive.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Airway Stenosis

Patients with lower airway stenosis on waiting list for endoscopic intervention on stenosis by respiratory endoscopy unit.

Treatment for 30 minutes with Heliox from a commercial tank (Oxhelⓒ, Air Liquideⓒ) with a fixed mixture of 70% helium and 30% oxygen with non-rebreather mask or reservoir bag at a flow of 12-15 lpm.

Andre navne:
  • Helium - Ilt

Treatment for 30 minutes with oxygen at FiO2 of 31% with Venturi mask.

Andre navne:
  • Ilt 31 %

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Changes in Neural Ventilatory Drive (%):
Tidsramme: 30 minutes with Heliox and 30 minutes with Oxygen 31%

Percentage over the Root Mean Square peak for parasternal electromyography (EMG): averaged of the square root of the peak value and the area under the curve of parasternal EMG (%RootMeanSquare) adjusted for respiratory frequency, as a surrogate of diaphragmatic EMG, and sternocleidomastoid EMG, which will give us information on accessory muscle activation.

30 minutes with Heliox and 30 minutes with Oxygen 31%

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Diaphragmatic excursion assessed with ultrasound
Tidsramme: At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.

Assessment of muscular effort by measuring the diaphragmatic excursion (mm) at tidal volume and at vital capacity.

At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
Thickening fraction of the diaphragm assessed by ultrasound
Tidsramme: At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.

Assessment of muscular effort by measuring the thickening fraction of the diaphragm in the apposition zone (%).

At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
Changes in thoracoabdominal synchrony
Tidsramme: Phase angle was calculated from 10 consecutive breaths at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Assessment of thoracoabdominal synchrony using thoracic and abdominal belts by calculating the phase angle with the Lissajoux loop method (plotting abdominal motion on the x-axis against thoracic motion on the y-axis).

Phase angle was calculated from 10 consecutive breaths at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Borg Scale Dyspnea evolution (points)
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Degree of dyspnea will be determined by this validated scale with a result between 1 and 10 points.0: Not at all 0.5: Very, very light (hardly noticeable) 1: Very light, 2: Light, 3: Moderate , 4: Somewhat intense, 5: Intense, 6: Between 5 and 7, 7: Very intense, 8: Between 7 and 9, 9: Very, very intense (almost maximum ), 10: Maximum

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Oxygen saturation
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Measured by pulse-oximetry

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Transcutaneous partial pressure of carbon dioxide
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Transcutaneous monitor uses a noninvasive technique to measure the skin-surface partial pressure of carbon dioxide (PtcCO2)

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Blood pressure
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Non-invasive measurement with a sphygmomanometer

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Heart rate
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

number of beats per minute

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Respiratory rate
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Number of breaths per minute

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Marta Corral Blanco, MD, Hospital 12 de Octubre

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

27. april 2022

Primær færdiggørelse (Faktiske)

31. maj 2023

Studieafslutning (Faktiske)

10. januar 2026

Datoer for studieregistrering

Først indsendt

30. maj 2024

Først indsendt, der opfyldte QC-kriterier

7. juni 2024

Først opslået (Faktiske)

13. juni 2024

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

23. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

18. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • HELIOX ON AIRWAY STENOSIS

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .